Tuesday 23 Apr 2024
By
main news image

SINGAPORE (May 11): Cordlife Group reported its fourth straight quarterly earnings as higher revenue from key markets and contributions from a newly-acquired subsidiary lifted profit from operations.

The pioneer in Asia’s private cord blood banking industry reported earnings of S$0.8 million in 3Q18, turning around from a net loss of S$0.4 million in 3Q17.

Revenue for the current quarter came in at S$17.7 million, 24.5% higher than S$14.2 million, mainly contributed by India and Singapore as well as the inclusion of the group’s newly acquired subsidiary, Healthbaby Biotech (Hong Kong) Co... (Click here to read the full story)

      Print
      Text Size
      Share